Managing hyperglycemia in hospitalized adults
March 27th 2023The 2012 Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline was recently reviewed by a panel of clinician experts for use in adults hospitalized with hyperglycemia.
In HFpEF, empagliflozin provides similar benefit for men and women
September 27th 2022An analysis of the landmark EMPEROR-Preserved trial is providing new insights into the effects of the SGLT2 inhibitor on heart failure outcomes based on patient sex in heart failure with preserved ejection fraction (HFpEF).